EMEUNET… Stats Made Simple: How to read a scientific paper? 22 Sep 2025 Reading a scientific paper is not always easy or appealing. Where to begin, which section to prioritise, how to approach the often-dense methods section? Depending on your career stage, this…
Annals of the Rheumatic Diseases… Autumn 2025 Press Review – Annals of Rheumatic Diseases 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Omar Dhrif Increasing the number of minor salivary glands from patients with Sjögren's disease improves the diagnostic and measurement precision of the histological focus score…
Arthritis Care and Research… Autumn 2025 Press Review – Arthritis Care and Research 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Antony Psarras Risk of Incident Heart Failure and Heart Failure Subtypes in Patients With Rheumatoid Arthritis Kawano et al. (10.1002/acr.25481) identified incident HF and categorized…
Arthritis and Rheumatology… Autumn 2025 Press Review – Arthritis & Rheumatology 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Antony Psarras Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib Kuley et al. (10.1002/art.43042) analysed markers of neutrophil activation,…
Press Review… Autumn 2025 Press Review – Arthritis Research & Therapy 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Clementina López-Medina Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster Curtis…
Press Review… Autumn 2025 Press Review – The Lancet Rheumatology 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Clementina López-Medina Baricitinib in early polymyalgia rheumatic (BACHELOR): a randomised, double-blind, placebo-controlled, parallel group trial Saraux A, et al. (10.1016/S2665-9913(24)00270-4) aimed to test whether baricitinib…
Miscellaneous… Autumn 2025 Press Review – Miscellanous 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Victoria Konzett Upadacitinib FDA and EMA-approved for treatment of giant cell arteritis after positive results from the SELECT-GCA study Blockmans et al. (10.1056/NEJMoa2413449) compared Upadacitinib…
Press Review… Autumn 2025 Press Review – Rheumatology (Oxford) 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Jacob J.E. Koopman ‘Am I doing this right?’ Physician perceptions of the global assessment in clinical trials of systemic sclerosis Sabanovic and colleagues (10.1093/rheumatology/keaf377) interviewed…
Press Review… Autumn 2025 Press Review – RMD Open 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Omar Dhrif Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study Bartoletti…
Press Review… Autumn 2025 Press Review – Seminars in Arthritis and Rheumatism 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Jacob J.E. Koopman Current evidence on switching between biologic therapies for Still’s disease: a systematic literature review Dagna and colleagues (10.1016/j.semarthrit.2025.152789) studied publications about the…